Business Standard

Wednesday, December 25, 2024 | 10:52 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Laurus Labs rebounds 9% from day's low after 3 straight sessions of decline

The management maintains positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio-- on the back of improving demand, and supported by capacity expansion plans planned

Laurus Labs
Premium

Laurus Labs

SI Reporter Mumbai
Shares of Laurus Labs moved higher by 6 per cent at Rs 643.80, bouncing back 9 per cent from its intra-day low, on the BSE on Friday on the back of a positive outlook. The stock of the pharmaceutical company hit an intra-day low of Rs 588.20 today and had declined for the third straight day.

It has underperformed the market and has fallen 10 per cent in the past two weeks, as against a 0.95 per cent decline in the S&P BSE Sensex till Thursday. Moreover, it has corrected 13 per cent from its record high level of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in